When mutated, the RAS protein is maintained in a constitutively active GTP-bound state, driving the downstream RAF/MEK/ERK (MAPK) kinase cascade and PI3K/AKT axis5, and enhancing cancer cell proliferation and survival. Here, MAP2K7 is linked to cancer.